Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04648540Phase 1Completed
Phase 1, randomised, double-blind trial of dexmedetomidine, Lidocaine Hydrochloride Injection, without epinephrine, pregabalin, acetaminophen, ketorolac and 1 more in Anesthesia (2 arms), sponsored by Cairo University. Primary endpoint: Extubation time at 24 hours. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04648540.